In a proof-of-concept study, researchers from the Icahn School of Medicine at Mount Sinai (NY, USA) have demonstrated the use of an experimental PET tracer in the diagnosis of chronic traumatic encephalopathy (CTE) in the living brain. At present, diagnosis is only possible after death, but this new study could pave the way for the development of an effective diagnostic tool for living patients.
Restricted Content / Members Only
You cannot view this content because It is available to members only. Please Login or Register to view this area.